426 related articles for article (PubMed ID: 21786226)
21. What is the role of direct renin inhibitors in the treatment of the hypertensive diabetic patient?
de la Sierra A; Salazar J
Adv Ther; 2011 Sep; 28(9):716-27. PubMed ID: 21809181
[TBL] [Abstract][Full Text] [Related]
22. Is there a future for direct renin inhibitors?
Chaudhary K; Nistala R; Whaley-Connell A
Expert Opin Investig Drugs; 2010 May; 19(5):653-61. PubMed ID: 20380486
[TBL] [Abstract][Full Text] [Related]
23. Aliskiren for renin inhibition: a new class of antihypertensives.
Van Tassell BW; Munger MA
Ann Pharmacother; 2007 Mar; 41(3):456-64. PubMed ID: 17341529
[TBL] [Abstract][Full Text] [Related]
24. Aliskiren as a novel therapeutic agent for hypertension and cardio-renal diseases.
Rashikh A; Ahmad SJ; Pillai KK; Najmi AK
J Pharm Pharmacol; 2012 Apr; 64(4):470-81. PubMed ID: 22420653
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of the renin angiotensin aldosterone system: focus on aliskiren.
Rao MS
J Assoc Physicians India; 2010 Feb; 58():102-8. PubMed ID: 20653151
[TBL] [Abstract][Full Text] [Related]
26. The efficacy of aliskiren, a direct renin inhibitor, in the treatment of hypertension.
Gradman AH; Traub D
Rev Cardiovasc Med; 2007; 8 Suppl 2():S22-30. PubMed ID: 17401313
[TBL] [Abstract][Full Text] [Related]
27. Direct renin inhibition: extricating facts from façades.
Juncos L
Ther Adv Cardiovasc Dis; 2013 Jun; 7(3):153-67. PubMed ID: 23487045
[TBL] [Abstract][Full Text] [Related]
28. Managing cardiovascular and renal risk: the potential of direct renin inhibition.
Sever PS; Gradman AH; Azizi M
J Renin Angiotensin Aldosterone Syst; 2009 Jun; 10(2):65-76. PubMed ID: 19502253
[TBL] [Abstract][Full Text] [Related]
29. Aliskiren, an orally effective renin inhibitor, provides antihypertensive efficacy alone and in combination with valsartan.
Pool JL; Schmieder RE; Azizi M; Aldigier JC; Januszewicz A; Zidek W; Chiang Y; Satlin A
Am J Hypertens; 2007 Jan; 20(1):11-20. PubMed ID: 17198906
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and safety of the direct renin inhibitor aliskiren and ramipril alone or in combination in patients with diabetes and hypertension.
Uresin Y; Taylor AA; Kilo C; Tschöpe D; Santonastaso M; Ibram G; Fang H; Satlin A
J Renin Angiotensin Aldosterone Syst; 2007 Dec; 8(4):190-8. PubMed ID: 18205098
[TBL] [Abstract][Full Text] [Related]
31. Renin inhibition with aliskiren.
Wuerzner G; Azizi M
Clin Exp Pharmacol Physiol; 2008 Apr; 35(4):426-30. PubMed ID: 18307734
[TBL] [Abstract][Full Text] [Related]
32. Current concepts: renin inhibition in the treatment of hypertension.
Gradman AH; Pinto R; Kad R
Curr Opin Pharmacol; 2008 Apr; 8(2):120-6. PubMed ID: 18308634
[TBL] [Abstract][Full Text] [Related]
33. Direct inhibition of renin: a physiological approach to treat hypertension and cardiovascular disease.
Ram CV
Future Cardiol; 2009 Sep; 5(5):453-65. PubMed ID: 19715410
[TBL] [Abstract][Full Text] [Related]
34. [Renin inhibition and the kidney].
Ecder T
Turk Kardiyol Dern Ars; 2009 Oct; 37 Suppl 7():28-31. PubMed ID: 20019474
[TBL] [Abstract][Full Text] [Related]
35. [Advantages and limitations of renin inhibition with aliskiren].
Azizi M; Frank M; Steichen O; Blanchard A
Ann Pharm Fr; 2011 May; 69(3):142-50. PubMed ID: 21570538
[TBL] [Abstract][Full Text] [Related]
36. A comparison of the tolerability of the direct renin inhibitor aliskiren and lisinopril in patients with severe hypertension.
Strasser RH; Puig JG; Farsang C; Croket M; Li J; van Ingen H
J Hum Hypertens; 2007 Oct; 21(10):780-7. PubMed ID: 17541390
[TBL] [Abstract][Full Text] [Related]
37. Aliskiren versus ramipril in hypertension.
Verdecchia P; Angeli F; Mazzotta G; Martire P; Garofoli M; Gentile G; Reboldi G
Ther Adv Cardiovasc Dis; 2010 Jun; 4(3):193-200. PubMed ID: 20418269
[TBL] [Abstract][Full Text] [Related]
38. [Renin as a target of direct pharmacological block in arterial hypertension].
Mukhin NA; Fomin VV
Ter Arkh; 2009; 81(8):5-9. PubMed ID: 19799192
[TBL] [Abstract][Full Text] [Related]
39. Efficacy, safety and tolerability of aliskiren, a direct renin inhibitor, in women with hypertension: a pooled analysis of eight studies.
Gradman AH; Weir MR; Wright M; Bush CA; Keefe DL
J Hum Hypertens; 2010 Nov; 24(11):721-9. PubMed ID: 20200550
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and safety profile of aliskiren: practical implications for clinicians.
Angeli F; Reboldi G; Poltronieri C; Angeli E; De Filippo V; Crocetti A; Bartolini C; D'Ambrosio C; Verdecchia P
Curr Drug Saf; 2014; 9(2):106-17. PubMed ID: 24517108
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]